iCare for Cancer Patients
- Status
- TERMINATED
- Phase
- NA
Clinical Trials Related to Myelodysplastic Syndromes
Related studies linked through entity extraction aliases.
Treatment of Anemia With Epoetin Beta in Low Risk Myelodysplastic Syndrome (MDS)
- Status
- COMPLETED
- Phase
- PHASE2
Lenalidomide After Allo-Hematopoietic Cell Transplant (HCT) in Acute Myelogenous Leukemia (AML) and Myelodysplastic Syndromes (MDS) Subjects With Minimal Residual Disease
- Status
- TERMINATED
- Phase
- PHASE1
Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Validation of a Predictive Model of Response to Romiplostim in Patients With IPSS Low or Intermediate-1 Risk MDS and Thrombocytopenia
- Status
- COMPLETED
- Phase
- PHASE2
A 5 Day Course of Fludarabine and Cytarabine Followed by Full Intensity Allogeneic Stem Cell Transplantation (FA5-Bucy) in Treating Patients With High-risk, Recurrent or Refractory Acute Leukemia and Advanced Myelodysplastic Syndrome
- Status
- UNKNOWN
- Phase
- N/A
Predictive Clinical and Biological Parameters in Acute Leukemia, Myelodysplastic Syndromes and Myeloproliferative Disorders-HEMATO-BIO-IPC-2013-015
- Status
- COMPLETED
- Phase
- NA
A Study of RO6870810/TEN-010 in Participants With Acute Myeloid Leukemia and Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE1
Post-transplantation Cyclophosphamide as GVHD Prophylaxis After HSCT
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Efficacy Study of CC-486 in Subjects With Myelodysplastic Syndromes
- Status
- COMPLETED
- Phase
- PHASE2
Study of TCP-ATRA for Adult Patients With AML and MDS
- Status
- COMPLETED
- Phase
- PHASE1
Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome
- Status
- RECRUITING
- Phase
- N/A
Extension Study to Evaluate Long-Term Effects of Luspatercept in Patients With Myelodysplastic Syndromes (MDS) (A536-05/MK-6143-003)
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Aezea® (Cenersen) in Transfusion Dependent Anemia Associated With Myelodysplastic Syndrome (MDS)
- Status
- TERMINATED
- Phase
- PHASE1
Phase I/II Trial to Investigate BI 836858 in Myelodysplastic Syndromes
- Status
- TERMINATED
- Phase
- PHASE2
Selective Inhibitor of Nuclear Export (SINE) Selinexor (KPT-330) in Patients With Myelodysplastic Syndromes
- Status
- COMPLETED
- Phase
- PHASE2
Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Trial of the Combination of Bortezomib and Clofarabine in Adults With Relapsed Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Volasertib in Combination With Azacitidine in Japanese Patients With Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Intra-Osseous Co-Transplant of UCB and hMSC
- Status
- COMPLETED
- Phase
- EARLY_PHASE1